MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from the sale and
maturity of marketable...
$48,782K
Proceeds from exercise of
stock options
$4,729K
Net cash provided by
investing activities
$21,549K
Net cash provided by
financing activities
$4,204K
Canceled cashflow
$27,233K
Canceled cashflow
$525K
Net (decrease)
increase in cash and cash...
-$14,673K
Canceled cashflow
$25,753K
Depreciation and
amortization
$25,212K
Share based
compensation
$16,146K
Other current and
non-current liabilities
$1,940K
Purchase of intangible
assets
$22,178K
Purchase of marketable
debt securities
$5,055K
Payment of guaranteed
minimum royalty
$525K
Net cash used in
operating activities
-$40,366K
Canceled cashflow
$43,298K
Effect of exchange rate
changes on cash
-$60K
Net loss from
continuing operations
-$36,602K
Accrued expenses
-$20,900K
Accounts payable
-$11,809K
Accounts receivable
$7,225K
Prepaid expenses and
other current and...
$6,382K
Inventory
$742K
Other
$4K
Back
Back
Cash Flow
source: myfinsight.com
Travere Therapeutics, Inc. (TVTX)
Travere Therapeutics, Inc. (TVTX)